ARCHIVES

Funding Opportunities

This article is from The Cancer Letter archive.

Vol. 28 No. 45 | December 6, 2002

Download PDF Visit The Full Archive

Related Articles

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Agents Not Indicated In Curative Setting.

August 8, 2008

Assumption, Not Facts Form Base For Regulation Of Carcinogens, One Regulatory Coucil consultant Says; request for Study By NSA Denied

June 8, 1979

NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises

July 21, 1989

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007